Please login to the form below

Not currently logged in
Email:
Password:

Kleemann joins Merck from Boehringer

Appointed head of group tax

Pharma finance veteran Sylvia Kleemann is to leave Boehringer Ingelheim to join rival German pharma firm Merck KGaA as head of group tax at the beginning of 2014.

Kleeman served as head of corporate tax at Boehringer and has additional life sciences experience at KPMG, Celanese and Fresenius Medical Care.

In her new role, she will report to chief financial officer Matthias Zachert. She replaces Armin Gembruch who has been head of group tax since May 2011.

Zachert said: “Sylvia Kleemann has extensive experience in both the pharmaceutical and the chemical industries. At the same time, Sylvia Kleemann has a very broad understanding of both public and family-owned companies, which makes her ideally suited for her new position at Merck.”

3rd December 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics